Polymorphs of darunavir
AssigneeMapi Pharma Ltd.
InventorEhud MAROM
Life of this patent
Estimating the term…
Abstract
The present invention provides new pseudopolymorphic forms of darunavir as well as a novel amorphous form of darunavir, pharmaceutical compositions comprising these compounds, methods for their preparation and use thereof in treating retroviral infections, in particular, HIV infection.
Claims14
A process for preparing a solid amorphous form of darunavir characterized by an IR spectrum with characteristic peaks at about 1454 and 1369 cm−1, the process comprising the steps of:
- (a) dissolving darunavir in CH2Cl2;
- and
- (b) evaporating the CH2Cl2 until a precipitate is formed.
A solid crystalline dimethylsulfoxide solvate of darunavir having an X-ray powder diffraction pattern with diffraction peaks at 2-theta values of about 20.6±0.1 and 21.2±0.1.
Dependencies are inferred from the claim text.